Literature DB >> 22278127

Neuroferritinopathy: a new inborn error of iron metabolism.

Michael J Keogh1, Patricia Jonas, Alan Coulthard, Patrick F Chinnery, John Burn.   

Abstract

Neuroferritinopathy is an autosomal dominant progressive movement disorder which occurs due to mutations in the ferritin light chain gene (FTL1). It presents in mid-adult life and is the only autosomal dominant disease in a group of conditions termed neurodegeneration with brain iron accumulation (NBIA). We performed brain MRI scans on 12 asymptomatic descendants of known mutation carriers. All three harbouring the pathogenic c.460InsA mutation showed iron deposition; these findings show pathological iron accumulation begins in early childhood which is of major importance in understanding and developing treatment for NBIA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278127      PMCID: PMC4038507          DOI: 10.1007/s10048-011-0310-9

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  23 in total

1.  The effect of age on the non-haemin iron in the human brain.

Authors:  B HALLGREN; P SOURANDER
Journal:  J Neurochem       Date:  1958-10       Impact factor: 5.372

2.  Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene.

Authors:  E Ohta; T Nagasaka; K Shindo; S Toma; K Nagasaka; K Ohta; Z Shiozawa
Journal:  Neurology       Date:  2008-04-15       Impact factor: 9.910

3.  Long-term improvement under deferiprone in a case of neurodegeneration with brain iron accumulation.

Authors:  A Kwiatkowski; G Ryckewaert; P Jissendi Tchofo; C Moreau; I Vuillaume; P F Chinnery; A Destée; L Defebvre; D Devos
Journal:  Parkinsonism Relat Disord       Date:  2011-08-06       Impact factor: 4.891

4.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Authors:  B Zhou; S K Westaway; B Levinson; M A Johnson; J Gitschier; S J Hayflick
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

5.  MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content.

Authors:  N Gelman; J M Gorell; P B Barker; R M Savage; E M Spickler; J P Windham; R A Knight
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

6.  Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights.

Authors:  Michelangelo Mancuso; Guido Davidzon; Roger M Kurlan; Rabi Tawil; Eduardo Bonilla; Salvatore Di Mauro; James M Powers
Journal:  J Neuropathol Exp Neurol       Date:  2005-04       Impact factor: 3.685

7.  Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene.

Authors:  Ana G Barbeito; Holly J Garringer; Martin A Baraibar; Xiaoying Gao; Miguel Arredondo; Marco T Núñez; Mark A Smith; Bernardino Ghetti; Ruben Vidal
Journal:  J Neurochem       Date:  2009-03-30       Impact factor: 5.372

8.  Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.

Authors:  Nicholas A Di Prospero; Angela Baker; Neal Jeffries; Kenneth H Fischbeck
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

Review 9.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

10.  Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.

Authors:  David Devos; P Jissendi Tchofo; Isabelle Vuillaume; Alain Destée; Stephanie Batey; John Burn; Patrick F Chinnery
Journal:  Brain       Date:  2008-10-14       Impact factor: 13.501

View more
  16 in total

Review 1.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 2.  Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach.

Authors:  Davide Tonduti; Luisa Chiapparini; Isabella Moroni; Anna Ardissone; Giovanna Zorzi; Federica Zibordi; Sergio Raspante; Celeste Panteghini; Barbara Garavaglia; Nardo Nardocci
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

3.  Harveian Oration 2019: Prediction and prevention in the genomic era.

Authors:  John Burn
Journal:  Clin Med (Lond)       Date:  2020-01       Impact factor: 2.659

Review 4.  Pathogenic mechanism and modeling of neuroferritinopathy.

Authors:  Anna Cozzi; Paolo Santambrogio; Maddalena Ripamonti; Ermanna Rovida; Sonia Levi
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

5.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

6.  Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN).

Authors:  Ethan Gore; Brian S Appleby; Mark L Cohen; Suzanne D DeBrosse; James B Leverenz; Bruce L Miller; Sandra L Siedlak; Xiongwei Zhu; Alan J Lerner
Journal:  Neurocase       Date:  2016-11-01       Impact factor: 0.881

Review 7.  Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA).

Authors:  Susanne A Schneider; Kailash P Bhatia
Journal:  J Neural Transm (Vienna)       Date:  2012-12-02       Impact factor: 3.575

8.  A novel ferritin light chain mutation in neuroferritinopathy with an atypical presentation.

Authors:  Katsuya Nishida; Holly J Garringer; Naonobu Futamura; Itaru Funakawa; Kenji Jinnai; Ruben Vidal; Masaki Takao
Journal:  J Neurol Sci       Date:  2014-04-12       Impact factor: 3.181

9.  Voxel-based analysis in neuroferritinopathy expands the phenotype and determines radiological correlates of disease severity.

Authors:  M J Keogh; B S Aribisala; J He; E Tulip; D Butteriss; C Morris; G Gorman; R Horvath; P F Chinnery; Andrew M Blamire
Journal:  J Neurol       Date:  2015-07-04       Impact factor: 4.849

10.  Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA).

Authors:  Susanne A Schneider; Petr Dusek; John Hardy; Ana Westenberger; Joseph Jankovic; Kailash P Bhatia
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.